Emerging evidence suggests that APOE polymorphisms may be implicated in the development and progression of various neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease, and multiple sclerosis [8,9]. The gene discussed is APOE; the disease is Alzheimer disease.